Primary pulmonary lymphoma
Updates to Article Attributes
Primary pulmonary lymphoma (PPL) refers to a clonal lymphoid proliferation affecting the lungs without any detectable extrapulmonary involvement. It is a much rarer type of pulmonary lymphoma and is most frequently represented by lymphoma of B cell lineage - often marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type.
Epidemiology
Primary pulmonary lymphoma is a very rare entity and is thought to only represent only 3-4% of extranodal non Hodgkin-Hodgkin lymphoma, <1% of a all non Hodgkin-Hodgkin lymphoma, and 0.5-1% of all primary pulmonary malignancies 1-6.
Radiographic features
The diagnosis of primary pulmonary lymphoma requires the following criteria at the time of initial writing (December 2012) 6.:
- involvement of lung, bronchus or both
are involved, without evidence of mediastinaladenopathylymphadenopathy oramass on a chest radiograph - no previous
extra-thoracicextrathoracic lymphoma - no evidence of
extra-thoracicextrathoracic lymphoma or lymphatic leukaemia at the time of diagnosis -
there is nono extrathoracic disease outsideofthe thorax for least three months following the initial diagnosis within the lung
When the lung is the principal site of lymphoma, the definition also includes:
- multifocal mucosa-associated lymphoid tissue (MALT) non-Hodgkin lymphoma
- pulmonary involvement with satellite nodes (hilar or mediastinal)
- multiorgan involvement by lymphomatoid granulomatosis, the clonal nature of which is controversial
Treatment and prognosis
This entity of lymphoma is thought to carry a comparatively good prognosis 4,5.
See also
-<p><strong>Primary pulmonary lymphoma (PPL)</strong> refers to a clonal lymphoid proliferation affecting the lungs without any detectable extrapulmonary involvement. It is a much rarer type of <a href="/articles/pulmonary-lymphoma">pulmonary lymphoma</a> and is most frequently represented by lymphoma of B cell lineage - often marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type.</p><h4>Epidemiology</h4><p>Primary pulmonary lymphoma is a very rare entity and is thought to only represent only 3-4% of extranodal non Hodgkin lymphoma, <1% of a all non Hodgkin lymphoma, 0.5-1% of all primary pulmonary malignancies <sup>1-6</sup>.</p><h4>Radiographic features</h4><p>The diagnosis of primary pulmonary lymphoma requires the following criteria at the time of initial writing (December 2012) <sup>6</sup>.</p><ul>-<li>involvement of lung, bronchus or both are involved without evidence of mediastinal adenopathy or a mass on a chest radiograph</li>-<li>no previous extra-thoracic lymphoma</li>-<li>no evidence of extra-thoracic lymphoma or lymphatic leukaemia at the time of diagnosis</li>-<li>there is no disease outside of the thorax for least three months following initial diagnosis within the lung</li>- +<p><strong>Primary pulmonary lymphoma (PPL)</strong> refers to a clonal lymphoid proliferation affecting the lungs without any detectable extrapulmonary involvement. It is a much rarer type of <a href="/articles/pulmonary-lymphoma">pulmonary lymphoma</a> and is most frequently represented by lymphoma of B cell lineage - often marginal zone B-cell lymphoma of <a title="MALT" href="/articles/inguinal-canal-walls-mnemonic">mucosa-associated lymphoid tissue (MALT)</a> type.</p><h4>Epidemiology</h4><p>Primary pulmonary lymphoma is a very rare entity and is thought to only represent only 3-4% of extranodal non-Hodgkin lymphoma, <1% of a all non-Hodgkin lymphoma, and 0.5-1% of all primary pulmonary malignancies <sup>1-6</sup>.</p><h4>Radiographic features</h4><p>The diagnosis of primary pulmonary lymphoma requires the following criteria at the time of initial writing (December 2012) <sup>6</sup>:</p><ul>
- +<li>involvement of lung, bronchus or both, without evidence of <a title="Mediastinal lymphadenopathy" href="/articles/mediastinal-lymph-node-enlargement">mediastinal lymphadenopathy</a> or <a title="Mediastinal mass" href="/articles/mediastinal-mass">mass</a> on a chest radiograph</li>
- +<li>no previous extrathoracic lymphoma</li>
- +<li>no evidence of extrathoracic lymphoma or lymphatic leukaemia at the time of diagnosis</li>
- +<li>no extrathoracic disease outside the thorax for least three months following the initial diagnosis within the lung</li>
-<li>multifocal mucosa-associated lymphoid tissue (MALT) non-Hodgkin lymphoma</li>- +<li>multifocal <a title="MALT lymphoma of lung" href="/articles/balt-lymphoma-1">mucosa-associated lymphoid tissue (MALT) non-Hodgkin lymphoma</a>
- +</li>